-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Maike Pharmaceutical-B (02335.HK) issued an announcement. The phase II clinical trial of MT200605, a drug candidate developed independently by the Group to treat acute ischemic stroke, has completed database locking.

Zhitongcaijing·07/24/2026 11:49:04
Listen to the news
Zhitong Finance App News, Maike Pharmaceutical-B (02335.HK) issued an announcement. The phase II clinical trial of MT200605, a drug candidate developed independently by the Group to treat acute ischemic stroke, has completed database locking.